Literature DB >> 33541131

The prognostic impact of renal function decline during hospitalization for myocardial infarction.

Otto Mayer1,2, Jitka Seidlerová1,2, Jan Bruthans1,3, Jan Opatrný4, Milan Hromádka4, Josef Jirák5, Jan Filipovský1,2.   

Abstract

Aim: We analyzed the mortality risk of myocardial infarction (MI) patients according to renal function, observed during hospitalization. Materials & methods: Patients hospitalized for MI between 2006 and 2018 were followed (n = 5659). We divided the sample into four groups by estimated glomerular filtration (eGFR) [ml/min]: normal functions (lowest eGFR during hospitalization >60); transiently moderate insufficiency (lowest eGFR >30 and ≤60, highest >60); permanently moderate insufficiency (highest eGFR >30 and ≤60); severe insufficiency (highest and lowest eGFR ≤30).
Results: Permanently moderate renal insufficiency indicates increased 5-years all-cause mortality (hazard risk ratio: 2.27 [95% CIs: 1.87-2.75], p < 0.0001), but a similar risk was found in patients with the only transient decline of renal functions (hazard risk ratio: 2.08 [95% CIs: 1.70-2.55], p < 0.0001). Both moderate insufficiency subgroups (transient/permanent) did not statistically differ regarding mortality risk.
Conclusion: Even just fluctuation of eGFR toward moderate insufficiency during hospitalization represents an important prognostic indicator in MI patients.

Entities:  

Keywords:  coronary artery disease; glomerular filtration; mortality risk; renal insufficiency

Mesh:

Year:  2021        PMID: 33541131     DOI: 10.2217/cer-2020-0085

Source DB:  PubMed          Journal:  J Comp Eff Res        ISSN: 2042-6305            Impact factor:   1.744


  1 in total

1.  The prognosis and therapeutic management of patients hospitalized for heart failure in 2010-2020.

Authors:  Otto Mayer; Jan Bruthans; Simona Bilkova; Jitka Seidlerova; Josef Jirak; Jan Filipovsky
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2022-04-20       Impact factor: 1.648

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.